LISATA THERAPEUTICS, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
LISATA THERAPEUTICS, INC. (LSTA) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $1.85 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.85M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.37M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.37M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.03M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost as first filed |
|---|---|---|
| 2025-12-31 | $1.85M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $2.37M 10-K · filed 2026-03-12 | |
| 2023-12-31 | $2.37M 10-K · filed 2025-02-27 | |
| 2022-12-31 | $3.03M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $3.09M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $5.03M 10-K · filed 2022-03-22 | |
| 2019-12-31 | $3.58M 10-K · filed 2021-02-25 | |
| 2018-12-31 | $6.39M 10-K · filed 2020-03-05 | |
| 2017-12-31 | $2.66M 10-K · filed 2019-03-14 | |
| 2016-12-31 | $11.56M 10-K · filed 2018-03-22 | $13.75M 10-K · filed 2017-03-17 |
| 2015-12-31 | $12.76M 10-K · filed 2017-03-17 | |
| 2014-12-31 | $9.58M 10-K · filed 2016-03-15 | |
| 2013-12-31 | $5.47M 10-K · filed 2016-03-15 | $7.97M 10-K · filed 2014-03-13 |
| 2012-12-31 | $5.47M 10-K · filed 2015-03-02 | |
| 2011-12-31 | $3.92M 10-K · filed 2013-03-11 | |
| 2010-12-31 | $2.39M 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |